Pentazocine And Naloxone
Product Images NDC 68387-531

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentazocine And Naloxone (NDC 68387-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Keltman Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pentazocine Figure 01)

Chemical structure diagram showing the molecular formula of pentazocine hydrochloride. The image depicts the arrangement of atoms and chemical bonds characteristic of the active ingredient pentazocine with the hydrochloride salt.*

FDA Label Image

Figure 2 (Pentazocine Figure 02)

Chemical structure diagram of the active ingredient in Pentazocine and naloxone, showing molecular connections and functional groups along with a hydrochloride (HCl) component.*

FDA Label Image

Label Image (Talwin Nx Lab)

Label for Pentazocine HCL/Naloxone HCL 50/0.5mg tablets from Keltman Pharmaceuticals, Inc. The label states this is a 60-tablet bottle of Generic Talwin NX, with usage instructions, storage conditions, and manufacturing and distribution details. The label also includes lot number 7H1167 and expiration date 8/2010, along with regulatory and cautionary information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.